Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul 29:16:564.
doi: 10.1186/s12885-016-2610-9.

The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients

Affiliations

The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients

Jorge J Castillo et al. BMC Cancer. .

Abstract

Background: Hyponatremia is prognostic of higher mortality in some cancers but has not been well studied in others. We used a longitudinal design to determine the incidence and prognostic importance of euvolemic and hypervolemic hyponatremia in patients following diagnosis with lymphoma, breast (BC), colorectal (CRC), small cell lung (SCLC), or non-small cell lung cancer (NSCLC).

Methods: Medical record and tumor registry data from two large integrated delivery networks were combined for patients diagnosed with lymphoma, BC, CRC, or lung cancers (2002-2010) who had ≥1 administration of radiation/chemotherapy within 6 months of diagnosis and no evidence of hypovolemic hyponatremia. Hyponatremia incidence was measured per 1000 person-years (PY). Cox proportional hazard models assessed the prognostic value of hyponatremia as a time-varying covariate on overall survival (OS) and progression-free survival (PFS).

Results: Hyponatremia incidence (%, rate) was 76 % each, 1193 and 2311 per 1000 PY, among NSCLC and SCLC patients, respectively; 37 %, 169 in BC; 64 %, 637 in CRC, and 60 %, 395 in lymphoma. Hyponatremia was negatively associated with OS in BC (HR 3.7; P = <.01), CRC (HR 2.4; P < .01), lung cancer (HR 2.4; P < .01), and lymphoma (HR 4.5; P < .01). Hyponatremia was marginally associated with shorter PFS (HR 1.3, P = .07) across cancer types.

Conclusions: The incidence of hyponatremia is higher than previously reported in lung cancer, is high in lymphoma, BC, and CRC and is a negative prognostic indicator for survival. Hyponatremia incidence in malignancy may be underestimated. The effects of hyponatremia correction on survival in cancer patients require further study.

Keywords: Cancer; Euvolemic; Hypervolemic; Hyponatremia; Survival.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Study flow chart
Fig. 2
Fig. 2
Proportion of patients with hyponatremia, by hyponatremia severity and cancer type
Fig. 3
Fig. 3
Kaplan Meier plot of overall survival across cancer types
Fig. 4
Fig. 4
Overall survival and progression-free survival across cancer types

References

    1. Verbalis JG, Goldsmith SR, Greenburg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126:S1–42. doi: 10.1016/j.amjmed.2013.07.006. - DOI - PubMed
    1. Mohan S, Gu S, Parikh A, Radhakrishnan J. Prevalence of hyponatremia and association with mortality: results from NHANES. Am J Med. 2013;126(12):1127–37. doi: 10.1016/j.amjmed.2013.07.021. - DOI - PMC - PubMed
    1. Castillo JJ, Vincent M, Justice E. Diagnosis and management of hyponatremia in cancer patients. Oncologist. 2012;17:756–65. doi: 10.1634/theoncologist.2011-0400. - DOI - PMC - PubMed
    1. Platania M, Verzoni E, Vitali M. Hyponatremia in cancer patients. Tumori. 2015;101(2):246–8. doi: 10.5301/tj.5000257. - DOI - PubMed
    1. Rosner MH, Dalkin AC. Electrolyte disorders associated with cancer. Adv Chronic Kidney Dis. 2014;21:7–17. doi: 10.1053/j.ackd.2013.05.005. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources